You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: June 20, 2024

Investigational Drug Information for Xanomeline


✉ Email this page to a colleague

« Back to Dashboard


What is the development status for investigational drug Xanomeline?

Xanomeline is an investigational drug.

There have been 10 clinical trials for Xanomeline. The most recent clinical trial was a Phase 2 trial, which was initiated on February 1st 2021.

The most common disease conditions in clinical trials are Schizophrenia and [disabled in preview]. The leading clinical trial sponsors are Karuna Therapeutics, Karuna Pharmaceuticals, and Zai Lab (Shanghai) Co., Ltd.

There are two hundred and forty-seven US patents protecting this investigational drug and two international patents.

Recent Clinical Trials for Xanomeline
TitleSponsorPhase
A Study to Assess the Efficacy and Safety of KarXT in Acutely Psychotic Hospitalized Chinese Adult Subjects With DSM-5 SchizophreniaZai Lab (Shanghai) Co., Ltd.Phase 3
A Study to Assess the Efficacy and Safety of KarXT in Acutely Psychotic Hospitalized Chinese Adult Subjects With DSM-5 SchizophreniaKaruna TherapeuticsPhase 3
An Open-label Study to Assess the Long-term Safety, Tolerability, Effectiveness, and Durability of Effect of KarXT in Patients With DSM-5 Diagnosis of SchizophreniaKaruna TherapeuticsPhase 3

See all Xanomeline clinical trials

Clinical Trial Summary for Xanomeline

Top disease conditions for Xanomeline
Top clinical trial sponsors for Xanomeline

See all Xanomeline clinical trials

US Patents for Xanomeline

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Xanomeline ⤷  Sign Up Micro-RNA, autoantibody and protein markers for diagnosis of neuronal injury Banyan Biomarkers, Inc. (Alachua, FL) The United States of America, as Represented by the Secretary of the Army (Washington, DC) ⤷  Sign Up
Xanomeline ⤷  Sign Up Methods of treating acanthamoeba infection using apocynin UNIVERSITY OF SOUTH FLORIDA (Tampa, FL) ⤷  Sign Up
Xanomeline ⤷  Sign Up WT1 peptide cancer vaccine composition for transdermal administration NITTO DENKO CORPORATION (Osaka, JP) OSAKA UNIVERSITY (Osaka, JP) ⤷  Sign Up
Xanomeline ⤷  Sign Up Vaccine composition NITTO DENKO CORPORATION (Osaka, JP) ⤷  Sign Up
Xanomeline ⤷  Sign Up Methods and compositions for treating schizophrenia THE JOHNS HOPKINS UNIVERSITY (Baltimore, MD) ⤷  Sign Up
Xanomeline ⤷  Sign Up Freeze dried drug nanosuspensions Janssen Pharmaceutica NV (Beerse, BE) ⤷  Sign Up
Xanomeline ⤷  Sign Up Muscarinic agonists Heptares Therapeutics Limited (Welwyn Garden, GB) ⤷  Sign Up
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Xanomeline

Drugname Country Document Number Estimated Expiration Related US Patent
Xanomeline China CN105189482 2033-02-07 ⤷  Sign Up
Xanomeline European Patent Office EP2953940 2033-02-07 ⤷  Sign Up
Xanomeline Spain ES2694299 2033-02-07 ⤷  Sign Up
Xanomeline Japan JP2016507548 2033-02-07 ⤷  Sign Up
Xanomeline Japan JP6478923 2033-02-07 ⤷  Sign Up
Xanomeline World Intellectual Property Organization (WIPO) WO2014122474 2033-02-07 ⤷  Sign Up
Xanomeline Australia AU2009282117 2028-08-11 ⤷  Sign Up
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.